- Investing Ideas
- US Artificial Intelligence (AI) Powered Medical Diagnosis Stocks
US Artificial Intelligence (AI) Powered Medical Diagnosis Stocks
Results
35
AI is revolutionizing medical diagnosis by leveraging advanced machine learning and data analytics to achieve unprecedented accuracy and speed. Trained on massive datasets of medical images, lab results, and patient histories, AI systems can detect conditions like cancer, heart disease, or neurological disorders earlier and more reliably than traditional methods, often spotting subtle patterns that elude human clinicians. For example, AI-powered tools are already surpassing radiologists in identifying tumors on X-rays or MRIs, reducing misdiagnoses and enabling earlier interventions. Beyond imaging, AI integrates real-time data from wearables—such as heart rate or glucose levels—to flag anomalies instantly, shifting diagnosis from reactive to proactive. While challenges like data quality and regulatory approval persist, AI’s diagnostic prowess promises to make healthcare more precise and timely, potentially saving countless lives through swift, accurate detection.
35 companies
Medtronic
Market Cap: US$100.3b
Develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally.
MDT
US$78.15
7D
1.5%
1Y
-3.4%
Siemens Healthineers
Market Cap: €38.5b
Through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China.
SHLD
€34.58
7D
2.1%
1Y
-28.1%
Siemens Healthineers
Market Cap: US$38.5b
Through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China.
SMMN.Y
US$20.17
7D
2.2%
1Y
-25.8%
Siemens Healthineers
Market Cap: US$38.5b
Through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China.
SEMH.F
US$40.32
7D
6.2%
1Y
-27.1%
Fresenius SE KGaA
Market Cap: €22.6b
A health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa.
FRED
€38.88
7D
0.4%
1Y
-9.4%
Fresenius SE KGaA
Market Cap: US$22.5b
A health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa.
FSNU.F
US$54.35
7D
0%
1Y
n/a
Fresenius SE KGaA
Market Cap: US$22.5b
A health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa.
FSNU.Y
US$11.84
7D
3.6%
1Y
-4.1%
Labcorp Holdings
Market Cap: US$21.1b
Provides laboratory services.
LH
US$255.75
7D
0.7%
1Y
5.7%
Olympus
Market Cap: US$2.0t
Manufactures and sells medical equipment in Japan, America, the Middle East, Asia, and Oceania.
OCPN.F
US$11.18
7D
9.3%
1Y
-13.4%
Olympus
Market Cap: US$2.0t
Manufactures and sells medical equipment in Japan, America, the Middle East, Asia, and Oceania.
OLYM.Y
US$11.63
7D
2.1%
1Y
-8.3%
Tempus AI
Market Cap: US$8.2b
Operates as a healthcare technology company in the United States.
TEM
US$46.49
7D
2.2%
1Y
-21.5%
Lantheus Holdings
Market Cap: US$6.3b
Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.
LNTH
US$94.47
7D
-2.3%
1Y
26.4%
RadNet
Market Cap: US$4.3b
Provides outpatient diagnostic imaging services in the United States and internationally.
RDNT
US$54.44
7D
1.9%
1Y
-4.1%
HeartFlow
Market Cap: US$2.4b
A medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide.
HTFL
US$29.20
7D
-9.4%
1Y
n/a
Tecan Group
Market Cap: US$1.9b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TCHB.F
US$177.00
7D
4.3%
1Y
-11.5%
Tecan Group
Market Cap: CHF 1.9b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECNZ
CHF 148.80
7D
10.8%
1Y
-11.4%
Cosmo
Market Cap: US$1.3b
A life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally.
CMOP.F
US$98.00
7D
1.6%
1Y
n/a
Cosmo
Market Cap: CHF 1.3b
A life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally.
COPNZ
CHF 79.20
7D
7.0%
1Y
48.0%
GeneDx Holdings
Market Cap: US$1.3b
A genomics company, provides genetic testing services.
WGS
US$47.33
7D
21.8%
1Y
-29.7%
Personalis
Market Cap: US$832.5m
Develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.
PSNL
US$8.25
7D
23.0%
1Y
78.6%
Veradigm
Market Cap: US$808.0m
A healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally.
MDRX
US$4.75
7D
-1.0%
1Y
8.0%
Guerbet
Market Cap: €327.8m
Provides a range of contrast media, medical devices, and digital and AI solutions for diagnostic and interventional imaging worldwide.
GBTP
€30.03
7D
0%
1Y
n/a
Nano-X Imaging
Market Cap: US$126.0m
Develops a commercial-grade tomographic imaging device with a digital X-ray source.
NNOX
US$1.91
7D
7.9%
1Y
-63.5%
Odysight.ai
Market Cap: US$92.8m
Develops, produces, and markets visual monitoring artificial intelligence (AI) solutions in Israel, the United States, and internationally.
ODYS
US$5.14
7D
13.7%
1Y
-0.2%
Spectral AI
Market Cap: US$77.3m
An artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States.
MDAI
US$2.64
7D
23.9%
1Y
92.7%
Acarix
Market Cap: US$311.0m
A medical device company, develops solutions for rapid AI-based coronary artery disease rule-out.
ACIX.F
US$0.023
7D
0%
1Y
-6.4%
TrivarX
Market Cap: US$32.3m
A health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States.
MDBI.F
US$0.0026
7D
0%
1Y
n/a
Aspira Women's Health
Market Cap: US$19.6m
Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States.
AWHL
US$0.42
7D
7.2%
1Y
500.0%
Light AI
Market Cap: US$24.5m
A healthcare technology company, focuses on the development of artificial intelligence and machine learning diagnostic digital healthcare solutions.
OHCF.F
US$0.15
7D
7.8%
1Y
-37.6%
20/20 Biolabs
Market Cap: US$13.5m
Develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases.
AIDX
US$1.21
7D
-12.7%
1Y
n/a
Renalytix
Market Cap: US$7.9m
Develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States.
RNLX.Y
US$1.26
7D
4.1%
1Y
-74.8%
Renalytix
Market Cap: US$7.9m
Develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States.
RENX.F
US$0.023
7D
0%
1Y
-79.0%
HeartSciences
Market Cap: US$6.1m
A medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness.
HSCS
US$1.94
7D
1.6%
1Y
-49.8%
EvokAI Creative Labs
Market Cap: US$874.6k
A MedTech artificial-intelligence (AI)-powered company, engages in the development of transformational technologies for the healthcare sector.
OKAI.F
US$0.17
7D
0%
1Y
n/a
America Great Health
Market Cap: US$21.2k
Operates as a biotechnology company in the United States.
AAGH
US$0.000001
7D
0%
1Y
-99.9%